Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Return on Sales (2016 - 2026)

Angiodynamics' Return on Sales history spans 17 years, with the latest figure at 0.1% for Q1 2026.

  • For Q1 2026, Return on Sales fell 4.0% year-over-year to 0.1%; the TTM value through Feb 2026 reached 0.1%, up 5.0%, while the annual FY2025 figure was 0.12%, 49.0% up from the prior year.
  • Return on Sales reached 0.1% in Q1 2026 per ANGO's latest filing, down from 0.08% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.58% in Q3 2023 to a low of 2.5% in Q1 2024.
  • Average Return on Sales over 5 years is 0.24%, with a median of 0.12% recorded in 2023.
  • Peak YoY movement for Return on Sales: plummeted -238bps in 2024, then surged 244bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.1% in 2022, then plummeted by -270bps to 0.37% in 2023, then surged by 60bps to 0.15% in 2024, then soared by 46bps to 0.08% in 2025, then decreased by -29bps to 0.1% in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Return on Sales are 0.1% (Q1 2026), 0.08% (Q4 2025), and 0.14% (Q3 2025).